Dynorphin-(1–13): The effect of in vivo treatment on opiate bindings in vitro
- 1 July 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 91 (1) , 95-99
- https://doi.org/10.1016/0014-2999(83)90367-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypesLife Sciences, 1981
- POSSIBLE REGULATORY ROLE OF DYNORPHIN ON MORPHINE-ENDORPHIN-INDUCED AND BETA-ENDORPHIN-INDUCED ANALGESIA1981
- Dynorphin: A possible modulatory peptide on morphine or β-endorphin analgesia in mouseEuropean Journal of Pharmacology, 1981
- Opioid peptide dynorphin-(1–13): Adsorptive losses and potency estimatesNeuropeptides, 1980
- Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in ratsLife Sciences, 1980
- Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.Proceedings of the National Academy of Sciences, 1980
- Dynorphin-(1-13), an extraordinarily potent opioid peptide.Proceedings of the National Academy of Sciences, 1979
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951